ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
信息服务
3.53
+0.0100
0.28%
成交量:
9.42万
成交额:
33.24万
市值:
1.70亿
市盈率:
60.66
高:
3.58
开:
3.49
低:
3.48
收:
3.52
数据加载中...
总览
公司
新闻
公告
【百利天恒:BL-B01D1(EGFR×HER3 双抗 ADC)联合用药治疗多种晚期实体瘤获 4 个 II 期药物临床试验批准通知书】金融界4月15日消息,百利天恒近日收到国家药品监督管理局正式批准签发的 4 个《药物临床试验批准通知书》,公司自主研发的创新生物药注射用 BL-B01D1(EGFR×HER3 双抗 ADC)的 4 个联合用药的 II 期临床试验获得批准。注射用 BL-B01D1 临床试验符合药品注册要求,同意开展联合仑伐替尼用于晚期肝癌、联合阿昔替尼±帕博利珠单抗用于晚期肾癌、联合贝伐珠单抗±化疗用于晚期结直肠癌、联合帕博利珠单抗±化疗用于晚期胆道恶性肿瘤的临床试验。BL-B01D1 是全球首创且唯一进入 III 期临床阶段的 EGFR×HER3 双抗 ADC,除本次新批准的 4 项临床试验外,正在中国和美国进行 30 余项针对十余种肿瘤类型的临床试验。药品需完成相关临床试验并通过审评、审批后方可上市销售,医药产品具有诸多特点,从研究到投产环节多,易受不确定性因素影响。
金融界
·
昨天
玉龙股份:本次终止上市事项开设现金选择权信息服务
美港电讯
·
昨天
万泰生物:九价HPV疫苗启动男性III期临床试验并完成首例受试者入组
美港电讯
·
04-14
两部门:推动乡村地名信息服务与寄递物流下乡、农村电商、普惠金融等深度融合
金十财经
·
04-13
【两部门:在邮政电商平台宣传推广“乡字号”、“土字号”等带有地名标识的土特产品】民政部、国家邮政局日前发布《关于加强地邮协作助力乡村振兴的通知》提出,推进“地名+邮政快递”利农惠农服务。充分发挥“互联网+地名服务+邮政快递”作用,推动乡村地名信息服务与寄递物流下乡、农村电商、普惠金融等深度融合,促进城乡资源要素双向流动。积极推广“地名+”模式,支持在乡村产业品牌宣传塑造中融入地名元素,在邮政电商平台宣传推广“乡字号”、“土字号”等带有地名标识的土特产品,助力乡村优质农副产品、旅游资源等推介推广。积极鼓励有意愿的邮递员、快递员等加入地名志愿服务队伍,参与地名文化建设、地名采集上图、相关技术推广等乡村地名公益服务,地名行政主管部门要在专业培训、技能提升以及关心关爱上予以支持。
金融界
·
04-13
玉溪沃森生物技术有限公司申请III类会议
金融界
·
04-13
港股异动 | 复宏汉霖(02696)涨近10% HLX43联合汉斯状临床研究完成首例给药 贝伐珠单抗眼科III期研究成功
智通财经
·
04-11
广州新济药业科技有限公司申请III类会议
金融界
·
04-11
美联储施密德:愿意重新评估资本和巴塞尔协议III。
金十财经
·
04-10
港股异动 | 康诺亚-B(02162)现涨近7% 司普奇拜单抗治疗季节性过敏性鼻炎III期数据优异
智通财经网
·
04-10
四环医药(00460):吡洛西利联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期期中分析结果刊登Nature子刊
金吾财讯
·
04-10
【四环医药(00460.HK):创新药吡洛西利联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期期中分析结果在《Nature Communications》学术期刊发表】四环医药(00460.HK)发布公告,本集团旗下非全资附属公司轩竹生物科技股份有限公司(轩竹生物)研发的创新药吡洛西利(Bireociclib)取得了重大科研突破,其联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期研究( BRIGHT-2,NCT05077449)期中分析结果,已正式刊登于顶级期刊Nature子刊《Nature Communications》。
金融界
·
04-10
四环医药(00460.HK):轩竹生物研发的创新药吡洛西利联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期期中分析结果在《Nature Communications》学术期刊发表
格隆汇
·
04-10
【券商聚焦】交银国际维持荣昌生物(09995)买入评级 指泰它西普gMG III期数据优于已上市竞品
金吾财讯
·
04-10
G-III服装集团盘中异动 下午盘快速上涨5.02%
市场透视
·
04-10
SoSoValue赋能Bybit推出VIP每日研报,AI内容引擎全面驱动洞察升级
Odaily
·
04-09
康泰生物:口服五价重配轮状病毒减毒活疫苗开启III期临床试验
美港电讯
·
04-09
贵州省互联网新闻信息服务单位许可信息(截至2025年3月31日)
多彩贵州网
·
04-09
G-III服装集团盘中异动 股价大跌5.05%
市场透视
·
04-09
百利天恒(688506.SH):BL-B01D1用于局部晚期或转移性尿路上皮癌III期临试完成首例受试者入组
智通财经
·
04-08
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/III/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服务","latestPrice":3.53,"timestamp":1744747200000,"preClose":3.52,"halted":0,"volume":94166,"delay":0,"floatShares":34437817,"shares":48255149,"eps":0.058194,"marketStatus":"盘前交易","change":0.01,"latestTime":"04-16 06:19:24 EDT","open":3.49,"high":3.575,"low":3.48,"amount":332447.7614542,"amplitude":0.026989,"askPrice":4.55,"askSize":100,"bidPrice":1.42,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.058194,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744810200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":3.53,"dividendRate":0.050992,"postHourTrading":{"tag":"盘后","latestPrice":3.53,"preClose":3.53,"latestTime":"19:51 EDT","volume":3224,"amount":11382.83,"timestamp":1744761099147},"volumeRatio":0.8049658656864792,"impliedVol":0.9339,"impliedVolPercentile":0.384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34437817,"roa":"1.59%","roe":"2.86%","lyrEps":0.058194,"volumeRatio":0.8049658656864792,"shares":48255149,"dividePrice":0.18,"high":3.575,"amplitude":0.026989,"preClose":3.52,"low":3.48,"week52Low":2.92,"pbRate":"1.77","psRate":"0.69","week52High":4.05,"institutionHeld":0.6217,"latestPrice":3.53,"committee":0.333333,"eps":0.058194,"divideRate":0.050992,"volume":94166,"delay":0,"ttmEps":0.058194,"open":3.49,"prevYearClose":3.34,"prevWeekClose":3.45,"prevMonthClose":3.91,"prevQuarterClose":3.91,"fiveDayClose":3.61,"twentyDayClose":3.66,"sixtyDayClose":3.2,"earningDate":1746633600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527464947","title":"【百利天恒:BL-B01D1(EGFR×HER3 双抗 ADC)联合用药治疗多种晚期实体瘤获 4 个 II 期药物临床试验批准通知书】金融界4月15日消息,百利天恒近日收到国家药品监督管理局正式批准签发的 4 个《药物临床试验批准通知书》,公司自主研发的创新生物药注射用 BL-B01D1(EGFR×HER3 双抗 ADC)的 4 个联合用药的 II 期临床试验获得批准。注射用 BL-B01D1 临床试验符合药品注册要求,同意开展联合仑伐替尼用于晚期肝癌、联合阿昔替尼±帕博利珠单抗用于晚期肾癌、联合贝伐珠单抗±化疗用于晚期结直肠癌、联合帕博利珠单抗±化疗用于晚期胆道恶性肿瘤的临床试验。BL-B01D1 是全球首创且唯一进入 III 期临床阶段的 EGFR×HER3 双抗 ADC,除本次新批准的 4 项临床试验外,正在中国和美国进行 30 余项针对十余种肿瘤类型的临床试验。药品需完成相关临床试验并通过审评、审批后方可上市销售,医药产品具有诸多特点,从研究到投产环节多,易受不确定性因素影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527464947","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527464947?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 17:25","pubTimestamp":1744709155,"startTime":"0","endTime":"0","summary":"金融界4月15日消息,百利天恒近日收到国家药品监督管理局正式批准签发的 4 个《药物临床试验批准通知书》,公司自主研发的创新生物药注射用 BL-B01D1 的 4 个联合用药的 II 期临床试验获得批准。BL-B01D1 是全球首创且唯一进入 III 期临床阶段的 EGFR×HER3 双抗 ADC,除本次新批准的 4 项临床试验外,正在中国和美国进行 30 余项针对十余种肿瘤类型的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15172549549379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","III","BK1515","BK0239","BK4023","BK1161","03347","BL","LU0757428866.USD","BK4080","BK1574","BK1576","BK1583","BK4134","688506","09939","LU1815336091.USD","159839","ADC","159938","BK4231"],"gpt_icon":0},{"id":"2527646371","title":"玉龙股份:本次终止上市事项开设现金选择权信息服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2527646371","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527646371?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 16:56","pubTimestamp":1744707371,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["601028","III","BK4134","BK0250","159982","BK0162","399300"],"gpt_icon":0},{"id":"2527188033","title":"万泰生物:九价HPV疫苗启动男性III期临床试验并完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2527188033","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527188033?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 16:53","pubTimestamp":1744620823,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603392","BK1141","BK4134","III","BK1583","LU1981816686.USD","BK0239","159646","03347","09633","BK1200","BK1576","BK1589"],"gpt_icon":0},{"id":"2527665079","title":"两部门:推动乡村地名信息服务与寄递物流下乡、农村电商、普惠金融等深度融合","url":"https://stock-news.laohu8.com/highlight/detail?id=2527665079","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527665079?lang=zh_cn&edition=fundamental","pubTime":"2025-04-13 20:00","pubTimestamp":1744545610,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["159792","BK4134","III","159940","160636"],"gpt_icon":0},{"id":"2527963011","title":"【两部门:在邮政电商平台宣传推广“乡字号”、“土字号”等带有地名标识的土特产品】民政部、国家邮政局日前发布《关于加强地邮协作助力乡村振兴的通知》提出,推进“地名+邮政快递”利农惠农服务。充分发挥“互联网+地名服务+邮政快递”作用,推动乡村地名信息服务与寄递物流下乡、农村电商、普惠金融等深度融合,促进城乡资源要素双向流动。积极推广“地名+”模式,支持在乡村产业品牌宣传塑造中融入地名元素,在邮政电商平台宣传推广“乡字号”、“土字号”等带有地名标识的土特产品,助力乡村优质农副产品、旅游资源等推介推广。积极鼓励有意愿的邮递员、快递员等加入地名志愿服务队伍,参与地名文化建设、地名采集上图、相关技术推广等乡村地名公益服务,地名行政主管部门要在专业培训、技能提升以及关心关爱上予以支持。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527963011","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527963011?lang=zh_cn&edition=fundamental","pubTime":"2025-04-13 19:12","pubTimestamp":1744542744,"startTime":"0","endTime":"0","summary":"充分发挥“互联网+地名服务+邮政快递”作用,推动乡村地名信息服务与寄递物流下乡、农村电商、普惠金融等深度融合,促进城乡资源要素双向流动。积极推广“地名+”模式,支持在乡村产业品牌宣传塑造中融入地名元素,在邮政电商平台宣传推广“乡字号”、“土字号”等带有地名标识的土特产品,助力乡村优质农副产品、旅游资源等推介推广。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/13191249512006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["III","159940","160636","159792","BK4134"],"gpt_icon":0},{"id":"2527693860","title":"玉溪沃森生物技术有限公司申请III类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2527693860","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527693860?lang=zh_cn&edition=fundamental","pubTime":"2025-04-13 05:08","pubTimestamp":1744492137,"startTime":"0","endTime":"0","summary":"金融界4月13日消息,据CDE官网沟通交流公示,于4月13日收到玉溪沃森生物技术有限公司申请的“III类会议”,当前状态“处理中”。玉溪沃森生物技术有限公司,成立于2005年,位于玉溪市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,玉溪沃森生物技术有限公司共对外投资了1家企业,参与招投标项目1096次,知识产权方面有商标信息11条,专利信息53条,此外企业还拥有行政许可392个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/13050849508933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0046","BK4134","BK0070","BK0077","300142","III","BK0239"],"gpt_icon":0},{"id":"2526688689","title":"港股异动 | 复宏汉霖(02696)涨近10% HLX43联合汉斯状临床研究完成首例给药 贝伐珠单抗眼科III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2526688689","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526688689?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 13:59","pubTimestamp":1744351180,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,复宏汉霖午后涨近10%,截至发稿,涨8.65%,报28.25港元,成交额1544.92万港元。此外,4月2日,复宏汉霖宣布HLX04-O治疗湿性年龄相关性黄斑变性中国患者的III期HLX04-O-wAMD-CN研究已成功达到预设的主要研究终点。基于该研究结果,复宏汉霖计划携手亿胜生物在中国递交HLX04-O的新药上市申请。HLX04-O有望成为中国首个获批用于眼科相关疾病治疗的贝伐珠单抗制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02696","BK4134","III"],"gpt_icon":0},{"id":"2526528575","title":"广州新济药业科技有限公司申请III类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2526528575","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526528575?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 06:06","pubTimestamp":1744322760,"startTime":"0","endTime":"0","summary":"金融界4月11日消息,据CDE官网沟通交流公示,于4月11日收到广州新济药业科技有限公司申请的“III类会议”,当前状态“处理中”。广州新济药业科技有限公司,成立于2007年,位于广州市,是一家以从事研究和试验发展为主的企业。通过天眼查大数据分析,广州新济药业科技有限公司共对外投资了4家企业,参与招投标项目18次,知识产权方面有商标信息32条,专利信息93条,此外企业还拥有行政许可33个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/11060649477540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["III","BK4134"],"gpt_icon":0},{"id":"2526591273","title":"美联储施密德:愿意重新评估资本和巴塞尔协议III。","url":"https://stock-news.laohu8.com/highlight/detail?id=2526591273","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526591273?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 22:58","pubTimestamp":1744297087,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK4550","US10Y.BOND","HK0000934320.USD","UPRO","US30Y.BOND","SDS","OEF","BK4504","ESmain","BK4588","US7Y.BOND","BK4134","SH","BK4585","BK4559","US6M.BOND",".SPX","SPXU","III","US2Y.BOND","US12M.BOND","SPY","BK4534","SSO","US3Y.BOND","US5Y.BOND","OEX","IVV","BK4581"],"gpt_icon":0},{"id":"2526329300","title":"港股异动 | 康诺亚-B(02162)现涨近7% 司普奇拜单抗治疗季节性过敏性鼻炎III期数据优异","url":"https://stock-news.laohu8.com/highlight/detail?id=2526329300","media":"智通财经网","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526329300?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 14:12","pubTimestamp":1744265520,"startTime":"0","endTime":"0","summary":"康诺亚-B现涨近7%,截至发稿,涨6.59%,报41.25港元,成交额5655.01万港元。消息面上,4月4日,司普奇拜单抗治疗SAR III期临床研究成果在Nature Medicine上发表,这是全球首个披露阳性数据的IL-4Rα单抗治疗SAR研究。该研究发现,对于经常规治疗仍未控制的中重度季节性过敏性鼻炎患者,新型生物制剂司普奇拜单抗可显著改善其临床症状及生活质量。华泰证券指出,过敏性鼻炎未满足需求庞大,司普奇拜单抗疗效优异。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-10/doc-inessiqu3153853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02162","BK1587","BK1574","BK4134","III","BK1583","BK1161"],"gpt_icon":0},{"id":"2526818309","title":"四环医药(00460):吡洛西利联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期期中分析结果刊登Nature子刊","url":"https://stock-news.laohu8.com/highlight/detail?id=2526818309","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526818309?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 13:11","pubTimestamp":1744261912,"startTime":"0","endTime":"0","summary":"金吾财讯 | 四环医药 公告,集团旗下非全资附属公司轩竹生物科技股份有限公司研发的创新药吡洛西利取得了重大科研突破,其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果,已正式刊登于顶级期刊Nature子刊《Nature Communications》。在此次试验里,吡洛西利联合氟维司群疗效显着。中位随访8.7个月时,联合组中位PFS达12.94个月,远超氟维司群组的7.29个月。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1956967","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK4225","III","HR","BK4134","BK1600","BK4203","BK1515"],"gpt_icon":0},{"id":"2526330688","title":"【四环医药(00460.HK):创新药吡洛西利联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期期中分析结果在《Nature Communications》学术期刊发表】四环医药(00460.HK)发布公告,本集团旗下非全资附属公司轩竹生物科技股份有限公司(轩竹生物)研发的创新药吡洛西利(Bireociclib)取得了重大科研突破,其联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期研究( BRIGHT-2,NCT05077449)期中分析结果,已正式刊登于顶级期刊Nature子刊《Nature Communications》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2526330688","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526330688?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 12:49","pubTimestamp":1744260552,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK)发布公告,本集团旗下非全资附属公司轩竹生物科技股份有限公司(轩竹生物)研发的创新药吡洛西利(Bireociclib)取得了重大科研突破,其联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期研究( BRIGHT-2,NCT05077449)期中分析结果,已正式刊登于顶级期刊Nature子刊《Nature Communications》。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/10124949451016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","BK1515","BK1574","BK1161","BK1191","BK1600","BK4203","159837","06978","III","HR","BK1593","159992","BK4225","00460"],"gpt_icon":0},{"id":"2526730595","title":"四环医药(00460.HK):轩竹生物研发的创新药吡洛西利联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期期中分析结果在《Nature Communications》学术期刊发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2526730595","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526730595?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 12:34","pubTimestamp":1744259687,"startTime":"0","endTime":"0","summary":"格隆汇4月10日丨四环医药宣布,集团旗下非全资附属公司轩竹生物科技股份有限公司研发的创新药吡洛西利取得了重大科研突破,其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果,已正式刊登于顶级期刊Nature子刊《Nature Communications》。研究从国内64个中心招募305例经内分泌治疗后进展的HR+╱HER2-晚期乳腺癌患者。在此次试验里,吡洛西利联合氟维司群疗效显著。中位随访8.7个月时,联合组中位PFS达12.94个月,远超氟维司群组的7.29个月。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/10123449450866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK4203","III","BK1191","06978","00460","159992","BK4134","HR","BK1161","BK4225","BK1600","BK1515","BK1574"],"gpt_icon":0},{"id":"2526432053","title":"【券商聚焦】交银国际维持荣昌生物(09995)买入评级 指泰它西普gMG III期数据优于已上市竞品","url":"https://stock-news.laohu8.com/highlight/detail?id=2526432053","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526432053?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 09:44","pubTimestamp":1744249440,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指,荣昌生物 泰它西普gMG III期数据优于已上市竞品:公司在AAN 2025上公布了泰它西普治疗gMG的中国内地III期研究结果。VYVGART治疗可能导致感染风险,相比之下泰它西普感染类AE发生率低于安慰剂组。而泰它西普优异的疗效和安全性能保证持续给药,从而使患者病情在长时间内保持稳定。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1956948","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","III","09995"],"gpt_icon":0},{"id":"2526831847","title":"G-III服装集团盘中异动 下午盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526831847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526831847?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 01:22","pubTimestamp":1744219341,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时22分,G-III服装集团股票出现波动,股价大幅拉升5.02%。截至发稿,该股报23.64美元/股,成交量29.0932万股,换手率0.66%,振幅8.71%。机构评级方面,在所有4家参与评级的机构中,25%的券商给予买入建议,50%的券商给予持有建议,25%的券商给予卖出建议。G-III服装集团股票所在的服装制造行业中,整体涨幅为2.23%。G-III服装集团公司简介:G-III Apparel Group Ltd 是一家纺织公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001222194d0f86d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041001222194d0f86d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4134","GIII","III"],"gpt_icon":0},{"id":"2526935593","title":"SoSoValue赋能Bybit推出VIP每日研报,AI内容引擎全面驱动洞察升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2526935593","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526935593?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 18:03","pubTimestamp":1744192992,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 AI 驱动的资管与投研平台 SoSoValue 宣布,已作为技术与内容提供方,支持 Bybit 面向 VIP 用户正式推出每日研报服务。该内容基于 SoSoValue 自研 AI 投研引擎和实时数据系统,由 Bybit 官方每日发布,聚焦加密市场核心动态,为高阶用户提供定制化、结构化、智能化的市场洞察内容。\nVIP 每日研报由 SoSoValue AI 系统驱动生成,涵盖六大模块:行业突发新闻、每日热币追踪、新币上线速递、今日必读资讯、价格结构分析及市场情绪监测。所有内容均基于 SoSoValue 的 AI 数据理解与动态识别能力,通过语义分析、数据聚合与逻辑建模,形成对市场实时状态的立体还原与深度解读。\nSoSoValue 投研引擎内建多项核心能力,包括趋势演化识别算法、社区情绪建模系统及事件级结构化新闻抽取技术。此次合作标志着 SoSoValue AI 内容服务能力的首次大规模落地应用,也验证了其在专业场景中为交易平台赋能的可行性与高适配性。\n未来,SoSoValue 将持续拓展 AI 内容服务能力,为更多平台型机构提供定制化内容模块、AI 快讯服务、智能投研集成解决方案,推动加密市场信息服务从“人工编辑”向“智能驱动”加速演进,构建新一代投资决策认知基础设施。\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/426443?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["III","BK4134","VIP"],"gpt_icon":0},{"id":"2526387079","title":"康泰生物:口服五价重配轮状病毒减毒活疫苗开启III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2526387079","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526387079?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 15:45","pubTimestamp":1744184747,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","III","BK1141","03347","159837","BK0046","BK1583","BK4134","BK1576","BK0201","300601","159646"],"gpt_icon":0},{"id":"2526238365","title":"贵州省互联网新闻信息服务单位许可信息(截至2025年3月31日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526238365","media":"多彩贵州网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526238365?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 13:51","pubTimestamp":1744177860,"startTime":"0","endTime":"0","summary":"根据《互联网新闻信息服务管理规定》(国家互联网信息办公室令第1号),通过互联网站、应用程序、论坛、博客、微博客、公众账号、即时通信工具、网络直播等形式向社会公众提供互联网新闻信息服务,应当取得互联网新闻信息服务许可。 自2017年6月《规定》实施以来,贵州省互联网信息办公室依法组织开展了许可审批相关工作。截至2025年3月31日,经贵州省互联网信息办公室审批的互联网新闻信息服务单位总计116家,具体服务形式包括:互联网站51个,应用程序77个,公众账号385个,共计513个服务项。 贵州省互联网信息办公室 2025年3月31日\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-09/doc-inespyir6131577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III","160636","159792","BK4134"],"gpt_icon":0},{"id":"2526443118","title":"G-III服装集团盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526443118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526443118?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 02:35","pubTimestamp":1744137332,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日02时35分,G-III服装集团股票出现异动,股价急速跳水5.05%。截至发稿,该股报23.02美元/股,成交量68.8217万股,换手率1.57%,振幅6.75%。机构评级方面,在所有4家参与评级的机构中,25%的券商给予买入建议,50%的券商给予持有建议,25%的券商给予卖出建议。G-III服装集团股票所在的服装制造行业中,整体跌幅为1.53%。G-III服装集团公司简介:G-III Apparel Group Ltd 是一家纺织公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409023532aa2c6313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409023532aa2c6313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4134","III","BK4202","GIII"],"gpt_icon":0},{"id":"2525425855","title":"百利天恒(688506.SH):BL-B01D1用于局部晚期或转移性尿路上皮癌III期临试完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2525425855","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525425855?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 15:49","pubTimestamp":1744098557,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百利天恒(688506.SH)公告,公司自主研发的创新生物药注射用BL-B01D1(EGFR×HER3双抗ADC)用于既往经含铂化疗及PD-1/PD-L1抑制剂治疗失败的不可手术切除的局部晚期或转移性尿路上皮癌患者的III期临床试验已于近日完成首例受试者入组,这是该产品第9项进入III期阶段的注册临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1275312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4023","688506","BK4134","III","LU1815336091.USD","BL","LU0757428866.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.04,"defaultRemindTime":1746734400000,"name":null,"time":"盘后","dateTimestamp":1746676800000,"actualEps":null},{"date":"2025-03-21","symbol":"III","amount":0.045,"announcedDate":"2025-03-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"market":"US","date":"2025-03-06","symbol":"III","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":0.02},{"date":"2024-12-03","symbol":"III","amount":0.045,"announcedDate":"2024-11-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-03","defaultRemindTime":1733236200000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-03","currency":"USD","dateTimestamp":1733202000000,"payDate":"2024-12-20"},{"market":"US","date":"2024-11-07","symbol":"III","fiscalQuarterEnding":"2024/09","expectedEps":0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2025-04-14","current":58.640459,"percent":0.951299,"low":-221.876594,"twenty":12.590422,"median":18.990743,"eighty":34.743602,"high":85.733259,"avg":5.155169,"sd":61.31986,"marketCap":166480264},"quantilePoints":[{"date":"2020-04-17","current":35.741483,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":119412296},{"date":"2020-04-24","current":33.77148,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":112830516},{"date":"2020-05-01","current":34.193624,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":114240897},{"date":"2020-05-08","current":37.007914,"twenty":20.050829,"median":32.238884,"eighty":49.624683,"marketCap":123643440},{"date":"2020-05-15","current":33.57217,"twenty":20.050829,"median":32.238884,"eighty":49.624683,"marketCap":96654276},{"date":"2020-05-22","current":28.776145,"twenty":20.050829,"median":32.183452,"eighty":49.624683,"marketCap":82846522},{"date":"2020-05-29","current":28.445385,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":81894263},{"date":"2020-06-05","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-06-12","current":33.406789,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96178146},{"date":"2020-06-19","current":33.241409,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":95702017},{"date":"2020-06-26","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-07-02","current":35.556731,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":102367829},{"date":"2020-07-10","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-17","current":34.23369,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":98558794},{"date":"2020-07-24","current":33.57217,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":96654276},{"date":"2020-07-31","current":33.90293,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":97606535},{"date":"2020-08-07","current":35.060591,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100939441},{"date":"2020-08-14","current":36.396194,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":112027485},{"date":"2020-08-21","current":34.990332,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":107700243},{"date":"2020-08-28","current":32.491023,"twenty":20.050829,"median":32.140184,"eighty":49.624683,"marketCap":100007369},{"date":"2020-09-04","current":33.272057,"twenty":20.050829,"median":32.145891,"eighty":49.624683,"marketCap":102411392},{"date":"2020-09-11","current":32.100506,"twenty":20.050829,"median":32.155221,"eighty":49.624683,"marketCap":98805357},{"date":"2020-09-18","current":33.896885,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":104334611},{"date":"2020-09-25","current":32.178609,"twenty":20.050829,"median":32.143037,"eighty":49.624683,"marketCap":99045759},{"date":"2020-10-02","current":32.64723,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":100488173},{"date":"2020-10-09","current":33.584471,"twenty":20.050829,"median":32.166915,"eighty":49.624683,"marketCap":103373001},{"date":"2020-10-16","current":32.803437,"twenty":20.050829,"median":32.195146,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-23","current":32.803437,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-30","current":32.022403,"twenty":20.050829,"median":32.29645,"eighty":49.624683,"marketCap":98564955},{"date":"2020-11-06","current":37.645849,"twenty":20.050829,"median":32.334816,"eighty":49.624683,"marketCap":115873923},{"date":"2020-11-13","current":37.83975,"twenty":20.050829,"median":32.470567,"eighty":49.624683,"marketCap":128692991},{"date":"2020-11-20","current":37.698557,"twenty":20.050829,"median":32.551135,"eighty":49.624683,"marketCap":128212793},{"date":"2020-11-27","current":45.040598,"twenty":20.050829,"median":32.61356,"eighty":49.624683,"marketCap":153183075},{"date":"2020-12-04","current":44.052247,"twenty":20.055618,"median":32.732778,"eighty":49.624683,"marketCap":149821691},{"date":"2020-12-11","current":44.617019,"twenty":20.096237,"median":32.786479,"eighty":49.624683,"marketCap":151742482},{"date":"2020-12-18","current":46.170143,"twenty":20.444658,"median":32.803437,"eighty":49.624683,"marketCap":157024657},{"date":"2020-12-24","current":42.781509,"twenty":20.563355,"median":32.855737,"eighty":49.624683,"marketCap":145499912},{"date":"2020-12-31","current":46.311336,"twenty":20.775561,"median":32.958394,"eighty":49.624683,"marketCap":157504855},{"date":"2021-01-08","current":49.417585,"twenty":21.565226,"median":33.007951,"eighty":49.624683,"marketCap":168069205},{"date":"2021-01-15","current":55.771274,"twenty":21.971704,"median":33.076029,"eighty":50.098483,"marketCap":189678103},{"date":"2021-01-22","current":50.829515,"twenty":22.396936,"median":33.127057,"eighty":50.207132,"marketCap":172871182},{"date":"2021-01-29","current":49.841164,"twenty":22.679784,"median":33.261363,"eighty":50.440112,"marketCap":169509798},{"date":"2021-02-05","current":52.523833,"twenty":22.936122,"median":33.272057,"eighty":50.716561,"marketCap":178633555},{"date":"2021-02-12","current":52.523833,"twenty":23.262797,"median":33.398429,"eighty":51.059228,"marketCap":178633555},{"date":"2021-02-19","current":53.794571,"twenty":23.609141,"median":33.417527,"eighty":51.276882,"marketCap":182955335},{"date":"2021-02-26","current":51.394288,"twenty":23.816947,"median":33.569725,"eighty":51.732235,"marketCap":174791973},{"date":"2021-03-05","current":53.088605,"twenty":24.140202,"median":33.57217,"eighty":51.962271,"marketCap":180554346},{"date":"2021-03-12","current":77.651845,"twenty":24.664612,"median":33.630766,"eighty":52.202094,"marketCap":213930833},{"date":"2021-03-19","current":71.502943,"twenty":26.272494,"median":33.737549,"eighty":52.523833,"marketCap":196990608},{"date":"2021-03-26","current":76.77343,"twenty":26.854371,"median":33.859576,"eighty":52.626372,"marketCap":211510801},{"date":"2021-04-01","current":78.003211,"twenty":26.956092,"median":33.90293,"eighty":52.747595,"marketCap":214898846},{"date":"2021-04-09","current":75.895016,"twenty":27.210395,"median":33.991802,"eighty":52.906055,"marketCap":209090769},{"date":"2021-04-16","current":76.422065,"twenty":27.379781,"median":34.193624,"eighty":53.109266,"marketCap":210542788},{"date":"2021-04-23","current":77.124796,"twenty":27.464698,"median":34.23369,"eighty":53.271145,"marketCap":212478813},{"date":"2021-04-30","current":79.935723,"twenty":27.596809,"median":34.39907,"eighty":53.663807,"marketCap":220222916},{"date":"2021-05-07","current":85.733259,"twenty":27.758845,"median":34.72983,"eighty":53.929654,"marketCap":236195128},{"date":"2021-05-14","current":34.582604,"twenty":27.90985,"median":34.72983,"eighty":53.929654,"marketCap":260718251},{"date":"2021-05-21","current":37.193814,"twenty":27.984267,"median":34.89521,"eighty":53.929654,"marketCap":280404160},{"date":"2021-05-28","current":37.32119,"twenty":28.127158,"median":35.060591,"eighty":53.929654,"marketCap":281364448},{"date":"2021-06-04","current":35.665301,"twenty":28.201568,"median":35.178625,"eighty":53.929654,"marketCap":268880701},{"date":"2021-06-11","current":36.811685,"twenty":28.275979,"median":35.34686,"eighty":53.929654,"marketCap":277523295},{"date":"2021-06-18","current":35.283172,"twenty":28.317177,"median":35.460054,"eighty":53.929654,"marketCap":265999836},{"date":"2021-06-25","current":35.983741,"twenty":28.42477,"median":35.600769,"eighty":53.929654,"marketCap":271281422},{"date":"2021-07-02","current":38.27651,"twenty":28.559204,"median":35.741483,"eighty":53.929654,"marketCap":288566610},{"date":"2021-07-09","current":38.212822,"twenty":28.661781,"median":35.920053,"eighty":53.929654,"marketCap":288086466},{"date":"2021-07-16","current":36.174805,"twenty":28.841499,"median":36.238493,"eighty":53.929654,"marketCap":272721854},{"date":"2021-07-23","current":38.085446,"twenty":29.02216,"median":36.365869,"eighty":53.929654,"marketCap":287126177},{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-14","current":58.640459,"twenty":12.590422,"median":18.990743,"eighty":34.743602,"marketCap":166480264}],"updateTime":1744776388858}}}